PathAI Secures $60M in Series B Funding Led by General Atlantic and Existing Investor General Catalyst BOSTON, April 17, 2019-- PathAI, a global provider of artificial intelligence-powered technology for pathology, announced today that it has raised $60 million in Series B funding. The round was led by new investor General Atlantic, a leading global growth equity firm, with strong participation from General Catalyst and other existing investors. The new capital will fuel PathAI’s continued expansion as the company seeks to advance the medical discipline of pathology.